Truscreen Group Ltd
NZX:TRU

Watchlist Manager
Truscreen Group Ltd Logo
Truscreen Group Ltd
NZX:TRU
Watchlist
Price: 0.022 NZD 4.76% Market Closed
Market Cap: 12.2m NZD
Have any thoughts about
Truscreen Group Ltd?
Write Note

Net Margin
Truscreen Group Ltd

-97.3%
Current
-261%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-97.3%
=
Net Income
-2.1m
/
Revenue
2.1m

Net Margin Across Competitors

Country NZ
Market Cap 12.2m NZD
Net Margin
-97%
Country US
Market Cap 204.9B USD
Net Margin
14%
Country US
Market Cap 195.2B USD
Net Margin
29%
Country US
Market Cap 146.7B USD
Net Margin
16%
Country US
Market Cap 132.6B USD
Net Margin
11%
Country IE
Market Cap 110.6B USD
Net Margin
12%
Country US
Market Cap 64.7B USD
Net Margin
9%
Country DE
Market Cap 55.6B EUR
Net Margin
8%
Country CN
Market Cap 319.2B CNY
Net Margin
34%
Country US
Market Cap 41.6B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

Truscreen Group Ltd
Glance View

Market Cap
12.2m NZD
Industry
Health Care

TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. The firm is engaged in the business of the development, manufacturing and sale of cancer detection devices and systems. Its cervical cancer screening device offers technology in cervical screening, providing detection of precancerous and cancerous cervical cells to help improve the health and well-being of women worldwide. Its real-time cervical cancer technology utilizes a digital wand, which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissues. A sophisticated algorithm framework is utilized to detect pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurement of cervical tissue. The product offers an approach to cervical screening, resolving ongoing issues with Pap smear (Pap tests), including failed samples, patient follow-up, patient discomfort and the need for supporting laboratory infrastructure.

TRU Intrinsic Value
0.02 NZD
Overvaluation 10%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-97.3%
=
Net Income
-2.1m
/
Revenue
2.1m
What is the Net Margin of Truscreen Group Ltd?

Based on Truscreen Group Ltd's most recent financial statements, the company has Net Margin of -97.3%.